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ascitic fluid with high fat (triglyceride) content, usually higher 
than 110 mg/dL. 
Chylous  fluid  in  the  peritoneal  cavity  is  a  rare  clinical 
condition  that  occurs  as  a  result  of  disruption  of  the 
abdominal lymphatics. Multiple causes have been described 
(table  I).  Congenital  chylous  ascites  is  the  commonest 
cause of chyloperitoneum in young children. Other causes 
in children include idiopathic or obstructive lesions caused 
by malrotation,  intussusception,  incarcerated  hernia, 
lymphangioma, blunt trauma, liver disease, and tuberculosis. 
In children, malrotation and volvulus contribute to chylous 
ascites3.  Volvulus  of  the  midgut  may  result  in  several 
manifestations. Venous and lymphatic obstructions occur first 
because of lower intravascular pressures. Vascular congestion 
leads to bowel oedema and possible oozing of blood, causing 
melaena. Lymphatic congestion causes the formation of a 
mesenteric cyst and chylous ascites. 
Milky ascites is subdivided into three groups: True chylous 
ascites  -  Fluid  with  high  triglyceride  content,  Chyliform 
ascites - Fluid with a lecithin-globulin complex due to fatty 
degeneration  of  cells,  and  Pseudochylous  ascites  -  Fluid 
that  is  milky  in  appearance  due  to  the  presence  of  pus. 
Dietary chylomicrons are absorbed in the small intestines 
and gradually pass along larger omental lymphatics to the 
cisterna chyli located anterior to the second lumbar vertebra. 
The cisterna is joined by the descending thoracic, right and 
left lumbar, and liver lymphatic trunks, and, collectively, these 
form the thoracic duct, which passes through the aortic hiatus 
and  courses  through  the  right  posterior  mediastinum  and 
eventually enters the venous system. The thoracic duct carries 
lymphatic drainage from the entire body, except for the right 
side of the head and neck, right arm, and right side of thorax. 
Chylous effusions develop when these channels are injured 
or obstructed.  Abdominal distension is the most common 
symptom, and rarely, it may present as acute peritonitis.  
As chylous peritonitis is a manifestation rather than a disease, 
the prognosis depends on the treatment of the underlying 
disease or cause. Few cases presenting as chylous peritonitis 
are reported in literature 
Three  cases  presenting  as  acute  appendicitis  have  been 
reported4,5.
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mesothelioma – “not just in the chest”
Editor,
Malignant deciduoid mesothelioma (MDM) is a rare phenotype 
of epithelioid mesothelioma, which most commonly occurs 
in the peritoneal cavity of young females. MDM remains 
a challenge even to the most astute diagnostician with the 
differential diagnosis being benign pseudotumoral deciduosis. 
It carries a dismal prognosis.
Case  Report:  A  previously  healthy  31-year-old  woman 
presented  with  a  short  history  of  increasing  abdominal 
girth  and  shortness  of  breath  without  weight  loss.  She 
smoked 15 cigarettes per day and had no risk factors for 
chronic liver disease or prior history of asbestos exposure. 
There was no family history of neurofibromatosis. Clinical 
examination  revealed  ascites  in  the  absence  of  signs  of 
chronic liver disease, café au lait spots or lymphadenopathy. 
Diagnostic paracentesis revealed no evidence of bacterial or 
mycobacterial infection. The serum ascites albumin gradient 
was 1.1g/dL. Cytology was consistent with benign reactive 
mesothelial cells although no leucocyte reaction was noted.
Haematological, tumour markers, inflammatory markers and 
biochemical parameters were in the normal range. A chest 
radiograph showed no signs of pericarditis, pleural plaques or 
effusions. Ultrasonographical and CT scanning demonstrated 
ascites with normal hepatic echotexture and anterograde flow 
in the portal vein. No thoracic lesions were seen. A diagnostic 
laparoscopy drained 9L of ascites and numerous small nodules 
were observed concentrated around the small bowel.
Histological examination of these nodules with conventional 
stains was consistent with a mesothelial process although it 
was impossible to differentiate between a benign reactive 
or  neoplastic  aetiology.  Typical  features  of  epitheliod 
mesothelioma were not observed. Further expert opinions 
were sought and immunostaining is shown in Figure 1. 
These findings were consistent with the diagnosis of MDM. 
Combination chemotherapy with pemetrexed and cisplatin 
was initiated but she required multiple hospital admissions 
Fig 1. Immunostaining revealed strong positivity for calretinin 
and cytokeratin which are considered to be sensitive and relatively 
specific markers for MDM. © The Ulster Medical Society, 2008.
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for therapeutic abdominal paracentesis. Our patient died 14 
months after diagnosis.
MDM  was  first  characterised  in  19941  and  accounts  for 
approximately  4%  of  all  mesotheliomas2.  In  contrast  to 
“classical” pleural mesothelioma, the most common site of 
disease is the peritoneum although a pleural form has been 
described. The most common presenting feature is ascites. 
There is a female preponderance (F = M ratio, 1.4:1) and 
younger age at presentation (<40 years). Rates of asbestos 
exposure are generally lower than “classical” mesothelioma 
(c.35%)2. 
MDM is a highly malignant neoplasm with mean survival time 
reported as 7.33 months (range 1-29.4 months)2. Treatment 
is not curative and the main therapeutic goal is symptomatic 
palliation. To date, there is no standard treatment for MDM. 
Using  established  regimens  for  peritoneal  mesothelioma, 
limited success has been observed using cytoreductive surgery 
and intraperitoneal hyperthermic chemotherapy3.
MDM  is  the  example  par  excellence  for  the  difficulties 
that  clinicians  face  in  the  differentiation  between  benign 
and  malignant  disease.  Moreover,  this  case  highlights 
the  usefulness  of  diagnostic  laparoscopy  in  investigating 
unexplained  ascites.  MDM  is,  and  is  likely  to  remain,  a 
diagnostic challenge for clinicians, even the astute ones.
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